Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vignesh Ravichandran

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 11, 2023
Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung CancerRohit Thummalapalli, Biagio Ricciuti, Chaitanya Bandlamudi, et al.
Medrxiv : the Preprint Server for Health Sciences|July 3, 2026
Integrated Clinicogenomic Risk Modeling for Metachronous Second Primary CancersJohnathan Amsalem, Irina Ostrovnaya, Andrew R Marderstein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 2, 2026
Neoadjuvant nivolumab with or without ipilimumab for cisplatin-ineligible patients with muscle-invasive bladder cancerBrendan J Guercio, Eugene J Pietzak, Vignesh Ravichandran, et al.
Cancer Discovery|September 23, 2016
A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast CancerJoseph Vijai, Sabine Topka, Danylo Villano, et al.
JCO Precision Oncology|June 1, 2023
Prevalence and Clinical Implications of Mismatch Repair-Proficient Colorectal Cancer in Patients With Lynch SyndromeMegha Ranganathan, Rosalba E Sacca, Magan Trottier, et al.
JCO Precision Oncology|September 21, 2020
Mutation Rates in Cancer Susceptibility Genes in Patients With Breast Cancer With Multiple Primary CancersKara N Maxwell, Brandon M Wenz, Abha Kulkarni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 2024
Microsatellite Instability, Tumor Mutational Burden, and Response to Immune Checkpoint Blockade in Patients with Prostate CancerAndrew T Lenis, Vignesh Ravichandran, Samantha Brown, et al.
JCO Precision Oncology|August 11, 2020
Understanding inherited risk in unselected newly diagnosed patients with endometrial cancerKaren A Cadoo, Diana L Mandelker, Semanti Mukherjee, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 23, 2021
Multiple Primary Cancers in Patients Undergoing Tumor-Normal Sequencing Define Novel AssociationsYing L Liu, Karen A Cadoo, Semanti Mukherjee, et al.
Journal of the National Cancer Institute|March 6, 2018
Prospective Evaluation of Germline Alterations in Patients With Exocrine Pancreatic NeoplasmsMaeve A Lowery, Winston Wong, Emmet J Jordan, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 11, 2023
Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung CancerRohit Thummalapalli, Biagio Ricciuti, Chaitanya Bandlamudi, et al.
Medrxiv : the Preprint Server for Health Sciences|July 3, 2026
Integrated Clinicogenomic Risk Modeling for Metachronous Second Primary CancersJohnathan Amsalem, Irina Ostrovnaya, Andrew R Marderstein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 2, 2026
Neoadjuvant nivolumab with or without ipilimumab for cisplatin-ineligible patients with muscle-invasive bladder cancerBrendan J Guercio, Eugene J Pietzak, Vignesh Ravichandran, et al.
Cancer Discovery|September 23, 2016
A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast CancerJoseph Vijai, Sabine Topka, Danylo Villano, et al.
JCO Precision Oncology|June 1, 2023
Prevalence and Clinical Implications of Mismatch Repair-Proficient Colorectal Cancer in Patients With Lynch SyndromeMegha Ranganathan, Rosalba E Sacca, Magan Trottier, et al.
JCO Precision Oncology|September 21, 2020
Mutation Rates in Cancer Susceptibility Genes in Patients With Breast Cancer With Multiple Primary CancersKara N Maxwell, Brandon M Wenz, Abha Kulkarni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 2024
Microsatellite Instability, Tumor Mutational Burden, and Response to Immune Checkpoint Blockade in Patients with Prostate CancerAndrew T Lenis, Vignesh Ravichandran, Samantha Brown, et al.
JCO Precision Oncology|August 11, 2020
Understanding inherited risk in unselected newly diagnosed patients with endometrial cancerKaren A Cadoo, Diana L Mandelker, Semanti Mukherjee, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 23, 2021
Multiple Primary Cancers in Patients Undergoing Tumor-Normal Sequencing Define Novel AssociationsYing L Liu, Karen A Cadoo, Semanti Mukherjee, et al.
Journal of the National Cancer Institute|March 6, 2018
Prospective Evaluation of Germline Alterations in Patients With Exocrine Pancreatic NeoplasmsMaeve A Lowery, Winston Wong, Emmet J Jordan, et al.
Pageof 5